You just read:

Auven Therapeutics and Bellus Health Announce Completion of Pivotal Phase 3 Confirmatory Trial of KIACTA™ for the Treatment of Orphan Disease AA Amyloidosis

News provided by

BELLUS Health Inc.

Jan 21, 2016, 08:20 ET